<div><table><tbody><tr>
<td></td>
<td></td>
</tr>
<tr>
<td>Venlafaxin</td>
<td>5</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Duloxetin</td>
<td>4</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Mianserin</td>
<td>2</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Agomelatin</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Propionic acid derivatives</td>
<td>19 (9.7%)</td>
<td>1.54 (1.14 to 2.07)</td>
<td>.005</td>
<td>1.47 (1.11 to 1.91)</td>
<td>.006</td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>18</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Dexibuprofen</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Drugs for urinary frequency and incontinence</td>
<td>14 (7.1%)</td>
<td>1.97 (1.37
to 2.79)</td>
<td>&lt;.001</td>
<td>1.36 (0.95 to 1.87)</td>
<td>.076</td>
</tr>
<tr>
<td>Mirabegron</td>
<td>8</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Tolterodine</td>
<td>4</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Solifenacin</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Trospium</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table></div>